10-K/A

                      SECURITIES AND EXCHANGE COMMISSION
                           Washington, D. C.  20549

                                  FORM 10-K/A
                                 AMENDMENT #1

               ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

                  For the fiscal year ended December 31, 1994
                         Commission File Number 1-6926

                               C. R. BARD, INC.
            (Exact name of registrant as specified in its charter)

       New Jersey                           22-1454160 
(State of incorporation)       (I.R.S. Employer Identification No.)

              730 Central Avenue, Murray Hill, New Jersey  07974
                   (Address of principal executive offices)

Registrant's telephone number, including area code: (908) 277-8000

          Securities registered pursuant to Section 12(b) of the Act:

      Title of each class       Name of each exchange on which registered

Common Stock - $.25 par value             New York Stock Exchange

       Securities registered pursuant to Section 12(g) of the Act:  None

Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days.  Yes  X     No      

Indicate by check mark if disclosure of delinquent filers pursuant
to Item 405 of Regulation S-K is not contained herein, and will not
be contained, to the best of registrant's knowledge, in definitive
proxy or information statements incorporated by reference in Part
III of this Form 10-K or any amendments to this Form 10-K. [ X ]

The aggregate market value of the voting stock held by
nonaffiliates of the registrant was approximately $1,394,100,000
based on the closing price of stock traded on the New York Stock
Exchange on February 28, 1995.  As of February 28, 1995, there were
52,115,526 shares of Common Stock, $.25 par value per share,
outstanding.

The Company's definitive Proxy Statement dated March 10, 1995 has
been incorporated by reference with respect to certain information
contained therein in Part III and Part IV of this Form 10-K.

The exhibit index is located in Part IV, Item 14, Page IV-1.

C. R. Bard, Inc. filed on March 17, 1995 its annual report on Form 10-K.
Due to a "submission" tag automatically being inserted by the EDGAR system
when merging the following exhibits, the EDGAR system did not accept these 
exhibits with the initial filing.  C. R. Bard, Inc. is hereby amending its
initial 10-K by refiling the following three exhibits:

     Exhibit 21     Parents and subsidiaries of registrant.

     Exhibit 23     Arthur Andersen LLP consent to incorporation by
                    reference of their report on Form 10-K as amended into
                    previously filed Forms S-8.

     Exhibit 27     Financial data schedule.

Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.

                                     C. R. BARD, INC.
                                       (Registrant)



                                 By: William C. Bopp  /s/         
                                     William C. Bopp   
                                     Senior Vice President and
                                     Chief Financial Officer

Date:  March 22, 1995

EX-21

                           C. R. BARD, INC. AND SUBSIDIARIES

EXHIBIT 21



Parents and Subsidiaries of Registrant

The following table lists, as of December 31, 1994, the Company of
its significant subsidiaries and indicates the jurisdiction of
organization of each subsidiary and the percentage of voting
securities owned by the immediate parent of each subsidiary.

                                             Where               % of    
                                          Incorporated       Voting Stock

C. R. Bard, Inc.                          New Jersey         (Registrant)
  Bainbridge Science, Inc.                Washington             100  
  Bard Access Systems, Inc.               Utah                   100
  Bard Canada Inc.                        Canada                 100
    Purchaseco Inc.                       Canada                 100
      Vas-Cath Holdings Ltd.              Canada                 100
        Vas-Cath, Inc.                    Canada                 100
        Med-Pro Design Inc.               Canada                 100
  Bard Cardiopulmonary, Inc.              Delaware               100
  Bard Devices, Inc.                      Delaware               100
    Davol Inc.                            Delaware               100
  Bard Implants, Inc.                     Delaware               100
  Bard International, Inc.                Delaware               100
    Bard Japan Limited                    Japan                  100
  Bard Shannon Limited                    Ireland                100
    Bard de Espana, S.A.                  Spain                  100
      C. R. Bard GmbH                     Germany                100
        Angiomed AG                       Germany                100
      Bard Portugal                       Portugal               100
    Bard Belgium N.V.                     Belgium                100
    Bard Galway Limited                   Ireland                100
    Bard Holdings Limited                 England                100
      Bard Limited                        England                100
    Bard Nederland B.V.                   Netherlands            100
    Bard S.P.A.                           Italy                  100
    C. R. Bard Ireland Limited            Ireland                100
    Laboratoires Bard S.A.                France                 100
      Cardial S.A.                        France                 100
  BCP Puerto Rico, Inc.                   Delaware               100
  Catalina Acquisition Corp.              Delaware               100
  CRB Delaware, Inc.                      Delaware               100
  Pilot Cardiovascular Systems, Inc.      Delaware               100
  Roberts Laboratories, Inc.              Arizona                100

The Consolidated Financial Statements include the accounts of the
Registrant and all its wholly-owned subsidiaries.

                                         IV-69

EX-23

                   C. R. BARD, INC. AND SUBSIDIARIES

EXHIBIT 23

               CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

As independent public accountants, we hereby consent to the incorporation by
reference of our report dated February 8, 1995, included in this Form 10-K,
into C. R. Bard, Inc.'s previously filed Registration Statements of Form S-8
for its Employees' Retirement Savings  Plan  of C. R. Bard, Inc.,
Registration No. 2-86291, the 1990 Employee Stock Option Plan, as amended,
Registration No. 33-35544 and the C. R. Bard, Inc. 1988 Directors Stock
Award Plan, as amended, and the 1993 Long Term Incentive Plan of C.R. Bard,
Inc., Registration No. 33-64874.




                                      Arthur Andersen LLP /s/
                                      Arthur Andersen LLP




Roseland, New Jersey
March 17, 1995











                                IV - 70

EX-27

 

<ARTICLE> 5
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1994
<PERIOD-END>                               DEC-31-1994
<CASH>                                          34,200
<SECURITIES>                                         0
<RECEIVABLES>                                  187,300
<ALLOWANCES>                                      7900
<INVENTORY>                                    199,200
<CURRENT-ASSETS>                               428,000
<PP&E>                                         199,900
<DEPRECIATION>                                 112,400
<TOTAL-ASSETS>                                 958,400
<CURRENT-LIABILITIES>                          364,600
<BONDS>                                         78,300
<COMMON>                                        13,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                     426,800
<TOTAL-LIABILITY-AND-EQUITY>                   958,400
<SALES>                                      1,018,200
<TOTAL-REVENUES>                             1,018,200
<CGS>                                          497,300
<TOTAL-COSTS>                                  370,200
<OTHER-EXPENSES>                                32,600
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,100
<INCOME-PRETAX>                                103,000
<INCOME-TAX>                                    28,100
<INCOME-CONTINUING>                             74,900
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    74,900
<EPS-PRIMARY>                                     1.44
<EPS-DILUTED>                                     1.44